Elodie Jouan

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Human liver cell-based assays for the prediction of hepatic bile acid efflux transporter inhibition by drugs.

Human liver cell-based assays for the prediction of hepatic bile acid efflux transporter inhibition by drugs.

Journal: Expert opinion on drug metabolism & toxicology

Published: January 12, 2025

Induction of drug metabolizing enzyme and drug transporter expression by antifungal triazole pesticides in human HepaSH hepatocytes.

Induction of drug metabolizing enzyme and drug transporter expression by antifungal triazole pesticides in human HepaSH hepatocytes.

Journal: Chemosphere

Published: June 23, 2024

Induction of human hepatic cytochrome P-450 3A4 expression by antifungal succinate dehydrogenase inhibitors.

Induction of human hepatic cytochrome P-450 3A4 expression by antifungal succinate dehydrogenase inhibitors.

Journal: Ecotoxicology and environmental safety

Published: December 12, 2023

Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors.

Inhibition of human drug transporter activities by succinate dehydrogenase inhibitors.

Journal: Chemosphere

Published: September 11, 2023

Interactions of organophosphate flame retardants with human drug transporters.

Interactions of organophosphate flame retardants with human drug transporters.

Journal: Ecotoxicology and environmental safety

Published: June 10, 2023

Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.

Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.

Journal: Biopharmaceutics & drug disposition

Published: July 10, 2022

Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity.

Substrate-Dependent Trans-Stimulation of Organic Cation Transporter 2 Activity.

Journal: International journal of molecular sciences

Published: October 31, 2021

Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.

Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.

Journal: European journal of drug metabolism and pharmacokinetics

Published: June 29, 2021

Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters.

Differential in vitro interactions of the Janus kinase inhibitor ruxolitinib with human SLC drug transporters.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: January 18, 2021

Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.

Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.

Journal: Expert opinion on drug metabolism & toxicology

Published: December 09, 2020

Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.

Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.

Journal: Fundamental & clinical pharmacology

Published: November 25, 2020

Differential interactions of carbamate pesticides with drug transporters.

Differential interactions of carbamate pesticides with drug transporters.

Journal: Xenobiotica; the fate of foreign compounds in biological systems

Published: May 19, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026